Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - NET INCOME
Net Income HRTX - Heron Therapeutics, Inc.
-111 M
LAST VALUE
29.22%
2 YEAR CAGR
9.17%
5 YEAR CAGR
-7.18%
10 YEAR CAGR